Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for National Healthcare (NHC) over the last 16 years, with FY2024 value amounting to $76.1 million.

  • National Healthcare's Cash & Equivalents rose 5403.09% to $130.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.6 million, marking a year-over-year increase of 5403.09%. This contributed to the annual value of $76.1 million for FY2024, which is 2890.94% down from last year.
  • According to the latest figures from FY2024, National Healthcare's Cash & Equivalents is $76.1 million, which was down 2890.94% from $107.1 million recorded in FY2023.
  • National Healthcare's 5-year Cash & Equivalents high stood at $147.1 million for FY2020, and its period low was $58.7 million during FY2022.
  • In the last 5 years, National Healthcare's Cash & Equivalents had a median value of $107.1 million in 2023 and averaged $99.3 million.
  • As far as peak fluctuations go, National Healthcare's Cash & Equivalents skyrocketed by 19223.39% in 2020, and later crashed by 4548.03% in 2022.
  • National Healthcare's Cash & Equivalents (Annual) stood at $147.1 million in 2020, then decreased by 26.84% to $107.6 million in 2021, then crashed by 45.48% to $58.7 million in 2022, then skyrocketed by 82.51% to $107.1 million in 2023, then fell by 28.91% to $76.1 million in 2024.
  • Its last three reported values are $76.1 million in FY2024, $107.1 million for FY2023, and $58.7 million during FY2022.